On December 12, 2022, Eli Lilly and Company (LLY) announced a new quarterly dividend of $1.13 per share, up 15.3% from the previous quarterly dividend of $0.98 per share. The pharmaceutical company has now raised its dividend for 9 consecutive years with similar 15% dividend hikes in the previous couple of years.
The next LLY dividend is payable on March 10, 2023 to shareholders of record at the close of business on Feb. 15, 2023. The new annual indicated rate to $4.52 per share, yields 1.2% at a stock price of $367.
Eli Lilly and Company is a manufacturer of human pharmaceutical products. It’s human pharmaceutical products include endocrinology products, neuroscience products, oncology products, immunology products and cardiovascular products. In the U.S., most of Lilly's pharmaceutical products are distributed through wholesalers that serve pharmacies, physicians and other health care professionals, and hospitals. Outside the U.S, the company promotes its products to healthcare providers primarily through sales representatives and on-line health care channels. The company's Elanco Animal Health division was fully separated from Eli Lilly in 2019. Eli Lilly and Company was incorporated in 1901 in Indiana to succeed to the drug manufacturing business founded in Indianapolis, Indiana, in 1876 by Colonel Eli Lilly.